368 related articles for article (PubMed ID: 18401431)
1. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
[TBL] [Abstract][Full Text] [Related]
2. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
3. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
Kanerva A; Wang M; Bauerschmitz GJ; Lam JT; Desmond RA; Bhoola SM; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
Mol Ther; 2002 Jun; 5(6):695-704. PubMed ID: 12027553
[TBL] [Abstract][Full Text] [Related]
5. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
[TBL] [Abstract][Full Text] [Related]
6. Fiber-modified adenoviruses for targeted gene therapy.
Wu H; Curiel DT
Methods Mol Biol; 2008; 434():113-32. PubMed ID: 18470642
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic adenovirus based on serotype 3.
Hemminki O; Bauerschmitz G; Hemmi S; Lavilla-Alonso S; Diaconu I; Guse K; Koski A; Desmond RA; Lappalainen M; Kanerva A; Cerullo V; Pesonen S; Hemminki A
Cancer Gene Ther; 2011 Apr; 18(4):288-96. PubMed ID: 21183947
[TBL] [Abstract][Full Text] [Related]
8. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
[TBL] [Abstract][Full Text] [Related]
9. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
10. Efficient infection of tumor endothelial cells by a capsid-modified adenovirus.
Shinozaki K; Suominen E; Carrick F; Sauter B; Kähäri VM; Lieber A; Woo SL; Savontaus M
Gene Ther; 2006 Jan; 13(1):52-9. PubMed ID: 16107861
[TBL] [Abstract][Full Text] [Related]
11. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
12. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
[TBL] [Abstract][Full Text] [Related]
13. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
[TBL] [Abstract][Full Text] [Related]
14. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
[TBL] [Abstract][Full Text] [Related]
15. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration.
Price AR; Limberis MP; Wilson JM; Diamond SL
Gene Ther; 2007 Nov; 14(22):1594-604. PubMed ID: 17898795
[TBL] [Abstract][Full Text] [Related]
17. [Experimental BCSC-1 gene therapy on nasopharyngeal carcinoma mediated by adenovirus].
Zhou YQ; Ju JY; Tian Y; Liu Y; Zhu LP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):208-10. PubMed ID: 18505127
[TBL] [Abstract][Full Text] [Related]
18. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
[TBL] [Abstract][Full Text] [Related]
19. Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein.
Toth K; Tarakanova V; Doronin K; Ward P; Kuppuswamy M; Locke JE; Dawson JE; Kim HJ; Wold WS
Cancer Gene Ther; 2003 Mar; 10(3):193-200. PubMed ID: 12637940
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]